Detail akcie Perrigo online

Business Summary: Perrigo Company plc is a pure-play self-care company. The Company provides health and wellness solutions. Its segments include Self Care, Specialty Care, and Infant Formula. Self Care comprises Upper Respiratory, Digestive Health, Pain & Sleep and Healthy Lifestyle product categories globally. Specialty Care comprises our Women's Health and Skin Health product categories globally. Infant Formula comprises the Infant Formula product category, which includes nutritional products designed to meet the dietary needs of infants. It provides a store-branded private label provider of self-care products in many categories, including upper respiratory, healthy lifestyle and women's health, along with brands including Opill and Mederma. Its Europe portfolio consists primarily of brands, including Compeed, ellaOne, Solpadeine, Jungle Formula, and ACO. Its upper respiratory products include Nasonex 24HR Energy, Mucus DM, All Day Allergy, Nighttime Cold & Flu, and Allergy Relief.
Financial Summary: BRIEF: For the three months ended 28 March 2026, Perrigo Company PLC revenues decreased 7% to $969.2M. Net loss applicable to common stockholders excluding extraordinary items totaled $389.9M vs. income of $100K. Revenues reflect Self Care segment decrease of 12% to $543.3M, Other segment decrease of 9% to $129.2M, United States segment decrease of 9% to $554.4M, Europe segment decrease of 5% to $391.4M.